ASOU - Overview: Arsenic Occupational Exposure, Random, Urine
Screening test for detection of occupational exposure to arsenic in random urine specimens
ASCU - Overview: Arsenic/Creatinine Ratio, Urine
Screening for arsenic exposure using random urine specimens
HTG2 - Overview: Thyroglobulin, Tumor Marker, Serum
Follow-up of patients with differentiated thyroid cancers after thyroidectomy and radioactive iodine ablation
LDALD - Overview: Lysosomal and Peroxisomal Disorders Newborn Screen, Blood Spot
First-tier newborn screen for the lysosomal disorders: Fabry, Gaucher, Krabbe, mucopolysaccharidosis I (MPS I) and II (MPS II), infantile neurovisceral or chronic visceral acid sphingomyelinase deficiency, and Pompe (glycogen storage...
HTGR - Overview: Thyroglobulin, Tumor Marker Reflex, Serum
Reporting of accurate thyroglobulin results, depending on the antithyroglobulin antibodies status of the patient Accurate measurement of serum thyroglobulin in patients with known or suspected antithyroglobulin autoantibodies or possible...
AMTRP - Overview: Amitriptyline and Nortriptyline, Serum
Monitoring amitriptyline and nortriptyline serum concentrations during therapy Evaluating potential amitriptyline and nortriptyline toxicity May aid in evaluating patient compliance
ASUOE - Overview: Arsenic Occupational Exposure, with Reflex, Random, Urine
Preferred screening test for detection of occupational exposure to arsenic in random urine specimens
ASUCR - Overview: Arsenic/Creatinine, Ratio, with Reflex, Random, Urine
Preferred screening test for detection of arsenic exposure using random urine specimens
ASU24 - Overview: Arsenic with Reflex, 24 Hour, Urine
Preferred screening test for detection of arsenic exposure using 24-hour urine specimens
LSD6W - Overview: Lysosomal Storage Disorders, Six-Enzyme Panel, Leukocytes
Diagnosis of the lysosomal storage disorders: Fabry (in male patients), Gaucher, Krabbe, mucopolysaccharidosis I (MPS I), acid sphingomyelinase deficiency (Niemann-Pick types A and B), and Pompe (glycogen storage disorder type II) This...